According to the report way of American national cancer think factory, the mortality of female ovary cancer wants the Gao to grow a system cancer a mortality at the other women.Predict this year that the estimate contains 20180 new-found example of ovary carcinomatosis.
The research express that the ovary cancer of the normal regulations’ examination’s method is to be subjected to the limiting and be unlike examination breast carcinoma so, can use X to only become to be like this mature of means.Currently didn’t°yet the very mature demulcent therapy, reconciliation correct ovary cancer examine a method.General be this kind of disease into development stage, the only pelvic examination can occasionally examine the cancer of proptosis ovary.Anyway, the blood which combines pelvic test, vagina ultrasonic wave and girdle to have CA125 the tumor marking tests a three specieses test method and can judge whether women get an ovary cancer or not.
South University of Florida and the H. Lee research center of the Moffitt cancer united to develop one species albuminuria, can to predict that the female ovary cancer contains higher accuracy.Follow sex research before the item here in, wet sample to come from 18 normally healthy volunteers and 38 to get normal gynecology paroxysm women and 35 to use Bcl ? 2 proteinase examinations to come out to be placed in an ovary cancer a not contemporaneous sufferer.Ovary cancer sufferer the Bcl ? of the in vivo examination the content of 2 proteinases want to compare health women of demulcent therapy, reconciliation normal sufferer’s content high proptosis of the gynecology disease 1000%.Pass determination Bcl ? 2 levels to judge an ovary cancer to contain 92% accuracies, but pass CA125 markings to examine the accuracy of ovary cancer to only have 68%.
The cardinal representative director should study the Patricia Kruk holds in Washington of American cancer research meeting up announced this a research a result.The representative director, pathology of American south tumor academics of the health association of the University of Florida and cytology associate professor Kruk say, “I only keep a careful optimistic attitude, we still need to carry on a lot of research works, and this is only a beginning.”
